Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lawrence Liberti

Showing results (21-30 of 29) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 29 results.
CMAJ Open|December 27, 2016
Evaluating alignment between Canadian Common Drug Review reimbursement recommendations and provincial drug plan listing decisions: an exploratory studyNicola Allen, Stuart R Walker, Lawrence Liberti, et al.
Drug Discovery Today|March 15, 2017
Factors related to drug approvals: predictors of outcome?Lawrence Liberti, Alasdair Breckenridge, Jarno Hoekman, et al.
Revista Panamericana De Salud Publica = Pan American Journal of Public Health|September 5, 2022
Regulatory reliance pathways during health emergencies: enabling timely authorizations for COVID-19 vaccines in Latin AmericaIvar T van der Zee, Rick A Vreman, Lawrence Liberti, et al.
Frontiers in Pharmacology|April 20, 2017
FDA Facilitated Regulatory Pathways: Visualizing Their Characteristics, Development, and Authorization TimelinesLawrence Liberti, Magda Bujar, Alasdair Breckenridge, et al.
The Oncologist|May 8, 2015
Observations on Three Endpoint Properties and Their Relationship to Regulatory Outcomes of European Oncology Marketing ApplicationsLawrence Liberti, Pieter Stolk, James Neil McAuslane, et al.
Plos Medicine|August 14, 2020
Improving access to quality medicines in East Africa: An independent perspective on the East African Community Medicines Regulatory Harmonization initiativeAlexander R Giaquinto, Alberto Grignolo, Lawrence Liberti, et al.
Journal of Public Health Policy|March 11, 2016
Accelerating access to new medicines: Current status of facilitated regulatory pathways used by emerging regulatory authoritiesLawrence Liberti, Alasdair Breckenridge, Jarno Hoekman, et al.
Therapeutic Innovation & Regulatory Science|September 22, 2018
Characterizing Good Review Practices: A Survey Report Among Agencies of APEC Member EconomiesLi-Ling Liu, Neil McAuslane, Meir-Chyun Tzou, et al.
Therapeutic Innovation & Regulatory Science|June 11, 2020
A Baseline Analysis of Regulatory Review Timelines for ANVISA: 2013-2016Prisha Patel, Daniela Marreco Cerqueira, Gustavo Mendes Lima Santos, et al.
Pageof 3

Showing results (21-30 of 29) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 29 results.
CMAJ Open|December 27, 2016
Evaluating alignment between Canadian Common Drug Review reimbursement recommendations and provincial drug plan listing decisions: an exploratory studyNicola Allen, Stuart R Walker, Lawrence Liberti, et al.
Drug Discovery Today|March 15, 2017
Factors related to drug approvals: predictors of outcome?Lawrence Liberti, Alasdair Breckenridge, Jarno Hoekman, et al.
Revista Panamericana De Salud Publica = Pan American Journal of Public Health|September 5, 2022
Regulatory reliance pathways during health emergencies: enabling timely authorizations for COVID-19 vaccines in Latin AmericaIvar T van der Zee, Rick A Vreman, Lawrence Liberti, et al.
Frontiers in Pharmacology|April 20, 2017
FDA Facilitated Regulatory Pathways: Visualizing Their Characteristics, Development, and Authorization TimelinesLawrence Liberti, Magda Bujar, Alasdair Breckenridge, et al.
The Oncologist|May 8, 2015
Observations on Three Endpoint Properties and Their Relationship to Regulatory Outcomes of European Oncology Marketing ApplicationsLawrence Liberti, Pieter Stolk, James Neil McAuslane, et al.
Plos Medicine|August 14, 2020
Improving access to quality medicines in East Africa: An independent perspective on the East African Community Medicines Regulatory Harmonization initiativeAlexander R Giaquinto, Alberto Grignolo, Lawrence Liberti, et al.
Journal of Public Health Policy|March 11, 2016
Accelerating access to new medicines: Current status of facilitated regulatory pathways used by emerging regulatory authoritiesLawrence Liberti, Alasdair Breckenridge, Jarno Hoekman, et al.
Therapeutic Innovation & Regulatory Science|September 22, 2018
Characterizing Good Review Practices: A Survey Report Among Agencies of APEC Member EconomiesLi-Ling Liu, Neil McAuslane, Meir-Chyun Tzou, et al.
Therapeutic Innovation & Regulatory Science|June 11, 2020
A Baseline Analysis of Regulatory Review Timelines for ANVISA: 2013-2016Prisha Patel, Daniela Marreco Cerqueira, Gustavo Mendes Lima Santos, et al.
Pageof 3